Journal of Diabetes Research / 2019 / Article / Tab 1

Research Article

Sleep-Disordered Breathing Is Associated with Metabolic Syndrome in Outpatients with Diabetes Mellitus Type 2

Table 1

Baseline characteristics.

Age (years)
Sex, male (n (%))412 (60.7%)
Metabolic parameters
Waist circumference (cm)
BMI (kg/m2)
Systolic BP (mmHg)
Diastolic BP (mmHg)
HDL (mg/dl)
Triglycerides (mg/dl)
Duration of DM2 (years)
HbA1c (%)
HOMA index
Medication N (%)
 Antihypertensive medication
  Antihypertensive medication altogether547 (81%)
  ACE inhibitor280 (41%)
  Angiotensin receptor blocker164 (24%)
  Renin inhibitor3 (<1%)
  Calcium channel blocker191 (28%)
  Beta-blocker322 (47%)
  Diuretics267 (39%)
 Fat metabolism
  HMG-CoA-reductase inhibitor318 (47%)
 Diabetes medication
  Antidiabetic agents altogether575 (85%)
  Biguanide459 (68%)
  Incretin153 (23%)
  Sulfonylurea127 (19%)
  Glinide26 (4%)
  Alpha-glucosidase inhibitor9 (1%)
  Exenatide6 (1%)
  Insulin181 (27%)

Results are provided as deviation or (%). AHI: apnea-hypopnea index; BMI: body mass index; BP: blood pressure; HbA1c: haemoglobin A1c; HOMA: Homeostasis Model Assessment (fasting, use of long-acting insulin); DM2: diabetes mellitus type 2; HDL: high-density lipoprotein; 413 patients included.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.